ARTICLE | Politics & Policy

SCOTUS remands Shire, Actavis

January 27, 2015 2:28 AM UTC

The U.S. Supreme Court Shire plc (LSE:SHP; NASDAQ:SHPG) and remanded to a lower court Shire's patent infringement suit against Actavis plc (NYSE:ACT), citing the high court's decision last week in Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) vs. the Sandoz International GmbH generics unit of Novartis AG (NYSE:NVS; SIX:NOVN).

Shire asked SCOTUS to review whether the U.S. Court of Appeals for the Federal Circuit (CAFC) overreached by reviewing de novo certain questions of fact in the company's lawsuit against Actavis plc (NYSE:ACT) rather than deferring to the findings of the U.S. District Court for the Southern District of Florida. ...